The rise of Sildenafil initially drove a surge for the drug industry, nevertheless recent developments present a murky picture for shareholders. Off-patent alternatives are eroding earnings, and ongoing litigation add https://saulyzql975016.jaiblogs.com/68251297/sildenafil-and-pharma-a-precarious-bet